Smith & Nephew PLC (SNN)
25.14
+0.10
(+0.42%)
USD |
NYSE |
Nov 22, 10:42
Smith & Nephew Shareholders Equity (Quarterly): 5.205B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.205B |
| June 30, 2024 | 5.205B |
| December 31, 2023 | 5.217B |
| June 30, 2023 | 5.233B |
| June 30, 2023 | 5.233B |
| December 31, 2022 | 5.259B |
| June 30, 2022 | 5.395B |
| June 30, 2022 | 5.395B |
| December 31, 2021 | 5.568B |
| June 30, 2021 | 5.331B |
| June 30, 2021 | 5.331B |
| December 31, 2020 | 5.279B |
| June 30, 2020 | 4.96B |
| June 30, 2020 | 4.96B |
| December 31, 2019 | 5.141B |
| June 30, 2019 | 4.952B |
| June 30, 2019 | 4.952B |
| December 31, 2018 | 4.874B |
| June 30, 2018 | 4.643B |
| June 30, 2018 | 4.643B |
| December 31, 2017 | 4.644B |
| June 30, 2017 | 4.201B |
| June 30, 2017 | 4.201B |
| December 31, 2016 | 3.958B |
| June 30, 2016 | 3.944B |
| Date | Value |
|---|---|
| June 30, 2016 | 3.944B |
| December 31, 2015 | 3.966B |
| June 30, 2015 | 4.049B |
| June 30, 2015 | 4.049B |
| December 31, 2014 | 4.04B |
| September 30, 2014 | 4.017B |
| June 30, 2014 | 4.155B |
| June 30, 2014 | 4.155B |
| March 31, 2014 | 4.216B |
| December 31, 2013 | 4.047B |
| September 30, 2013 | 3.911B |
| June 30, 2013 | 3.895B |
| March 31, 2013 | 3.953B |
| December 31, 2012 | 3.884B |
| September 30, 2012 | 3.642B |
| June 30, 2012 | 3.557B |
| March 31, 2012 | 3.453B |
| December 31, 2011 | 3.187B |
| September 30, 2011 | 3.057B |
| June 30, 2011 | 3.133B |
| March 31, 2011 | 3.003B |
| December 31, 2010 | 2.773B |
| September 30, 2010 | 2.478B |
| June 30, 2010 | 2.31B |
| March 31, 2010 | 2.226B |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
4.96B
Minimum
Jun 2020
5.568B
Maximum
Dec 2021
5.247B
Average
5.233B
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| Haleon PLC | 21.00B |
| Adaptimmune Therapeutics PLC | 79.99M |
| Biodexa Pharmaceuticals PLC | 11.04M |
| Verona Pharma PLC | 130.49M |
| NuCana PLC | 4.806M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.54B |
| Total Liabilities (Quarterly) | 5.337B |
| Debt to Equity Ratio | 0.6669 |
| Current Ratio | 2.509 |
| Net Debt Paydown Yield | -2.45% |